Is AI Hype in Drug Development About to Turn Into Reality?
The world of drug discovery, long characterised by years of painstaking trial-and-error, is undergoing a seismic transformation. Recent research led...
Read moreDetailsThe world of drug discovery, long characterised by years of painstaking trial-and-error, is undergoing a seismic transformation. Recent research led...
Read moreDetailsToday’s ESG Updates US Retreats From UN Climate Treaty: The EU condemns the United States’ decision to withdraw from the...
Read moreDetailsToday’s ESG Updates Vast Resources Under Greenland's Ice: Untapped critical and rare-earth mineral deposits emerge, along with questions about mining...
Read moreDetailsToday’s ESG Updates Big Oil Still Locked Out of Venezuela: Analysts say security sanctions and legal risks block large scale...
Read moreDetailsTen years ago, I embedded in the war on coal. I spent a month inside the Sierra Club’s Beyond Coal campaign, watching an organization...
Read moreDetails
Impakter informs you through the ESG news site and empowers your business CSRD compliance and ESG compliance with its Klimado SaaS ESG assessment tool marketplace that can be found on: www.klimado.com
Registered Office Address
Klimado GmbH
Niddastrasse 63,
60329, Frankfurt am Main, Germany
IMPAKTER is a Klimado GmbH website
Impakter is a publication that is identified by the following International Standard Serial Number (ISSN) is the following 2515-9569 (Printed) and 2515-9577 (online – Website).
Office Hours - Monday to Friday
9.30am - 5.00pm CEST
stories [at] impakter.com
© 2026 IMPAKTER. All rights reserved.